Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Issue 2026-10-08Oct 8, 2026

Web View

Terumo's $610mn plasma-contract loss, Rorze's chip backlog and a food tax cut without deficit bonds

Terumo expects about $610mn of losses from a plasma contract it has agreed to end, Rorze's chip backlog tops ¥100bn, and the finance minister says the food tax cut will skip deficit bonds.

MARKETS

Market pulse

As of: October 8, 2026 JST
Nikkei 22569,042.11-1.42%
TOPIX4,091.46-1.51%
JPX Prime 150 Index1,726.4-1.52%
USD/JPY158.19+0.05%
10Y JGB yield3.111%+0.8 bps

Tokyo equities softened while the 10Y JGB yield nudged higher.

Sourced from Nikkei, JPX, BOJ, MOF - values, not commentary.

TSE Prime investor flows

Net buying (+) / selling (−)

InvestorWeek ending
Foreign net flow+¥982.6bn
Individual net flow+¥186.7bn
Trust-bank net flow+¥180.2bn

Japan Exchange Group, investor-type weekly trading value (TSE Prime)

lead

Terumo and CSL Plasma

Editorial illustration of medical device production equipment beside a split ledger showing a large impairment block and a smaller transition-cost block.

Terumo ends CSL Plasma supply deal and cuts profit guidance by 38%

Terumo agrees to end CSL Plasma supply deal and cuts profit guidance by 38% Terumo expects about $610mn of losses from a plasma-collection supply contract it has agreed with CSL Plasma to end, and has cut its operating profit forecast to ¥160bn from ¥257.5bn while adjusted operating profit stays at ¥274.5bn.

What changed: Terumo announced on October 8 that it and CSL Plasma agreed to terminate the supply contract after an agreed transition period. Terumo Blood and Cell Technologies, a wholly owned subsidiary known as Terumo BCT, began working with CSL Plasma in 2021 and supplied plasma-collection systems to centres CSL Plasma runs in the United States. Terumo said it will now proceed with termination procedures under the agreed transition plan. The length of the transition period is not disclosed.

The number: The total financial impact is about $610mn (about ¥97.5bn). About $450mn (about ¥72.0bn) is a non-cash impairment on manufacturing equipment, machinery, product technology and other assets at its US production base. The remaining $160mn or so (about ¥25.5bn) covers business losses during the transition plus termination and restructuring costs. Terumo says all amounts are approximate and may change with contract negotiations, transition terms and asset valuations.

Why it matters: The forecast cut falls on reported profit; the adjusted measure is unchanged. Operating profit is now forecast at ¥160bn, down 37.9%, and profit attributable to owners of the parent at ¥120bn from ¥193.1bn. Revenue is forecast at ¥1.2295tn, down 0.8%. Terumo expects the impairment to lower future amortisation and lift adjusted operating profit by about ¥2bn, and expects about ¥2bn of research and other costs from the Arsenal Medical acquisition announced September 30. Both are in the new forecast. For comparison, the year to March 2026 produced operating profit of ¥176.3bn.

What to watch: Terumo says it will keep putting resources into its core blood and cell technology business. An extraordinary report says the losses will be booked under 'other expenses' from the second quarter and from the third quarter onward of the year to March 2027. Terumo also amended its bond shelf registration (¥200bn cap, ¥160bn of available capacity) to add that report; the amendment states no bond issue plan.

Read more

secondary

Policy and Macro Watch

Illustration of budget line items being trimmed from stacked tokens to fund a basket of groceries, representing a food tax cut paid for by spending reviews.

Katayama says food tax cut will be paid for without deficit bonds, naming subsidy reviews and a slimmer supplementary budget

Katayama says food tax cut will be paid for without deficit bonds Japan's finance minister said the food consumption-tax cut will not rely on special deficit bonds, and that the roughly ¥3tn a year of cost-of-living spending in recent supplementary budgets will be reviewed.

What changed: Asked on October 6 to back up Prime Minister Takaichi's October 5 assurance that funding was no cause for worry, Katayama pointed to the outline the cabinet approved on September 15. Katayama said the government will work within a 'budget-compilation reform' framework: watch tax revenue, review spending and revenue together, and set a fiscal scale that lets the debt-to-GDP ratio fall steadily. The minister named a more visible 'Japan-style DOGE' effort, a thorough review of tax breaks, subsidies and funds, and a zero-based push for more non-tax revenue.

The catch: Supplementary budgets will be limited to truly urgent measures. Recent ones carried roughly ¥3tn a year for cost-of-living relief in each of the 2023, 2024 and 2025 fiscal years, and Katayama said the content of that spending will be revisited. The briefing gives no cost estimate for the tax cut and no start date.

Read more
Editorial illustration contrasting an active factory line with idle half-built house frames on a construction site.

Bank of Japan's nine regions all report recovery, with housing the soft spot

All nine regions in the Bank of Japan's October Regional Economic Report describe their economies as recovering moderately, picking up, or picking up moderately, though some weakness was seen in part.

What changed: Three regions changed their overall wording since July. Tohoku moved to 'recovering moderately' from 'picking up', and Shikoku to 'picking up' from 'picking up moderately'. Kyushu-Okinawa kept its July assessment but attributed its residual weakness mainly to the 2026 Kumamoto Earthquake. The report marks changes in pace with arrows, so wording alone does not make a formal upgrade or downgrade. It is an assessment compiled for the October 8 meeting of branch general managers, not a policy decision.

Details: Business fixed investment is the firmest line: eight regions describe it as increasing and Kyushu-Okinawa as at a high level. Employment and income are improving in every region. Housing investment is the weak spot, described as weak in Tokai and Shikoku and relatively weak in Hokkaido, Kanto-Koshinetsu, Chugoku and Kyushu-Okinawa. Four regions, Hokkaido, Hokuriku, Kanto-Koshinetsu and Kyushu-Okinawa, say price rises still weigh on consumption.

Read more

Japan's banks hold problem loans at ¥8.4tn, but disposal losses rise ¥0.3tn

Disclosed problem credit at Japanese banks did not grow in the year to March 2026, but the cost of dealing with it did.

What changed: The Financial Services Agency put claims disclosed under the Financial Reconstruction Act at ¥8.4tn at end-March 2026, unchanged from a year earlier. Within that, need-attention claims were ¥2.0tn, doubtful claims ¥5.3tn and bankrupt or effectively bankrupt claims ¥1.1tn. The ratio of problem claims to total credit was 1.0% for all banks against 1.1% a year earlier. The figures cover the 106 banks in the FSA's national-bank aggregate; credit associations and cooperatives are reported separately.

The number: Disposal losses were ¥535.5bn for the year, against ¥242.5bn the year before. The provision charge was ¥366.3bn, up from ¥61.4bn, while direct write-offs and similar items eased to ¥164.9bn from ¥177.7bn. For city banks, former long-term credit banks and trust banks, disposal losses were ¥315.2bn against ¥52.9bn. Reserves alone covered 28.0% of disclosed claims, down from 29.1%.

Bottom line: A flat stock alongside a larger loss line means the balance sheet and the income statement are telling different stories about the same year.

Read more

secondary

Earnings and Activists

A wafer-handling robot loads a carrier into a stocker in a cleanroom, with stacked carriers rising like a bar chart in the foreground.

Rorze lifts operating profit forecast 39% as chip-equipment backlog passes ¥100bn

Rorze now expects operating profit of ¥53.078bn for the year to February 2027, up from ¥38.112bn, and has raised its planned year-end dividend to ¥28 from ¥20.

What changed: The company attributes the upgrade to strong semiconductor demand. Revenue is forecast at ¥180.007bn, up from ¥159.021bn, and net profit attributable to owners of the parent at ¥37.779bn, up from ¥27.809bn. For the six months to August 31, revenue rose 21.5% to ¥79.733bn and operating profit rose 42.4% to ¥23.096bn.

The number: Semiconductor-equipment orders in the half came to ¥120.54bn, 256.4% of the prior-year level, and the backlog stood at ¥103.863bn, 229.8% of a year earlier. Rorze credits a sharp rise in sorter and stocker orders from a North American memory maker, which it does not name, plus more orders from Chinese equipment makers. Applied Materials accounted for 21.7% of sales and Taiwan Semiconductor Manufacturing Company for 14.6%.

What to watch: Rorze's own table puts the second-half requirement at ¥100.273bn of revenue and ¥29.981bn of operating profit, so the second half has to be larger than the first. The presentation lists long lead times on purchased parts as a risk, and Rorze has brought forward the start of its new Vietnam plant to the fourth quarter of 2027 from the first quarter of 2028.

Read more
Editorial illustration contrasting a Japanese convenience-store food counter with a U.S. fuel-station store, with unequal stacks of coins beneath each to show diverging profit.

Seven & i's overseas stores drive profit growth as Japan's 7-Eleven slips

Seven & i Holdings' operating profit rose 11.5% to ¥232.3bn in the six months to August 2026, even as reported operating revenue fell 2.8% to ¥5.46tn.

What changed: The revenue decline is largely a consolidation effect: Seven Bank and its subsidiaries left the group's consolidation on June 24, 2025, and York Holdings' subsidiaries on September 1, 2025. Net profit attributable to owners of the parent rose 2.2% to ¥124.4bn.

Details: Overseas convenience-store operating profit was ¥150.4bn against ¥109.9bn in Japan, where it was 90.2% of the prior year. At 7-Eleven, Inc., operating profit was $1,320mn, 145.8% of a year earlier, with fuel contributing $398mn of a $414mn rise in the company's profit bridge. At Seven-Eleven Japan, same-store sales rose 1.1%; the company points to up-front investment in in-store cooking equipment and next-generation store systems, plus inflation, as costs that outran sales.

What to watch: The company left its full-year forecast unchanged at revenue of ¥10.43tn, operating profit of ¥425bn and net profit of ¥278bn. Interim operating profit was 99.3% of its revised plan, with the domestic business at 91.3% of plan and overseas at 103.0%. On August 3 it bought 189,663,300 of its own shares for ¥400.0bn at ¥2,109 each.

Read more

Oasis lifts M3 stake to 9.48% and plans to add more than 5 points

Oasis Management now holds 9.48% of M3, up from 8.46%, and says it intends to raise its holding ratio by more than 5 percentage points within three months of October 1.

What changed: The Cayman Islands fund manager holds 64,352,600 shares, according to a change report filed on October 8. It reports on-market purchases on most trading days from August 3 to October 1, and the filing puts acquisition funding at ¥106.8bn, all fund money, with no borrowings.

The catch: The buying plan is conditional. It depends on M3's share price being at a level Oasis judges undervalued and on other factors, and the filing says purchases could fall after the three-month window. It is an intention, not a completed purchase.

What to watch: The filing says Oasis is already making proposals to M3 on delisting and on material changes in capital policy, including an outside party acquiring a majority of voting rights. Over the next 12 months it plans to make proposals on further subjects, among them removing a representative director, board composition, business transfers and dividend policy.

Read more

quick hits

Quick Hits

  • Fast Retailing lifts year-end dividend forecast to ¥530 from ¥320

    Fast Retailing now forecasts a ¥530 year-end dividend, up from ¥320, taking the annual total to ¥850 a share from ¥640, and says stronger cash generation covers both growth investment and higher shareholder returns.

    Read more
  • Yoshinoya raises full-year profit goal to ¥10bn but warns costs will keep climbing

    Yoshinoya Holdings beat its first-half forecasts and raised its full-year operating profit goal to ¥10bn from ¥8.5bn, while warning that raw material and labor costs will rise further in the second half.

    Read more
  • Sugi lifts sales guide on Seki Yakuhin but cuts every profit line

    Sugi Holdings lifted its full-year sales forecast to ¥1.118tn after consolidating Seki Yakuhin, but trimmed operating profit guidance to ¥51.0bn, saying a poor summer weighed on seasonal goods at existing stores.

    Read more
  • Nihon M&A Center sets up outside panel to test directors' responsibility for excess dividends

    Nihon M&A Center Holdings has formed a five-member independent committee to establish how two interim dividends exceeded the legal limit and to examine whether directors are responsible, with a report expected in late October 2026.

    Read more
  • Ikegami Tsushinki postpones interim results as cyberattack leaves accounting servers isolated

    Ikegami Tsushinki has postponed its 12 November interim results after isolating accounting servers following unauthorized access, saying full system recovery will take time and that it will announce a new date once one is decided.

    Read more
  • Optimus Group drops OzCar exit plan and moves the Australian affiliate toward administration

    Optimus Group's board has resolved to put its 30%-owned Australian affiliate OzCar into voluntary administration, reversing a May plan to exit the alliance, with its loans, guarantees and earnings impact still under review.

    Read more
  • Ono Pharmaceutical to pay Biohaven $80mn upfront for Asian rights to Graves' disease drug

    Ono Pharmaceutical will pay Biohaven $80mn upfront, $20mn in development milestones and a royalty of about 20% of sales for Asian rights to three IgG-degrading drugs, led by BHV-1300, now in phase 3 for Graves' disease.

    Read more
  • Nonresidents were net sellers of almost ¥7tn of securities in September

    Nonresidents were net sellers of equities and short-term debt in September while buying long-term debt, leaving a total net disposal of just under ¥7tn in the Ministry of Finance's designated-investor data, against ¥3.20tn on the narrower subtotal.

    Read more
  • FSA panel to weigh lighter rules for lending to large companies and the capital floor for nonbank bonds

    Papers for an October 9 FSA working group ask whether moneylenders serving only large companies should face lighter registration, renewal and paperwork rules, and whether the ¥1bn capital floor for nonbank bond issuers should stay.

    Read more
  • Japan will pay half the cost of remote shutoff systems for small gas utilities, up to ¥20mn

    Small gas pipeline operators can claim half the cost of remote pressure-regulator monitoring, capped at ¥20mn a year, but only for contracts signed after approval; the first application window closes on 28 October.

    Read more